According to the FDA (Food and Drug Administration), users of Onglyza have higher risks of congestive heart failure. An FDA advisory committee meeting decided that Onglyza suppliers should update their cautionary label and mention that consuming Onglyza may lead to heart failure. Previously, suppliers didn’t mention this fact, and so, many users were unaware of this risk.
Do you know you are eligible to file a Los Angeles Onglyza lawsuit against the manufacturer if you or any of your loved ones die after taking these tablets? AstraZeneca, one of the renowned companies producing Onglyza, has a team of experienced Mass Tort lawyers in Los Angeles to sort out such lawsuits in case the company’s reputation is at stake.
If you aren’t sure about how to file a lawsuit or whom to go to, you should contact Rueb Stoller Daniel to review your case during a free consultation.
The Link Between Onglyza and Heart Failure
Every year, thousands of men and women in America die due to cardiovascular disease. In fact, it is one of the leading causes of death in the USA. According to the CDC, there are approximately 647,000 deaths every year because of this disease. That’s almost 1 in every 4 deaths in America.
If cardiovascular disease alone isn’t scary, people with type-2 diabetes consuming Onglyza are at a higher risk of severe health issues. The FDA had recently conducted an investigation to see why and how the drug is related to heart failure after noticing the alarming number of deaths in the US. The reports from the investigation brought shivers down the spine of many as it indicated high risks of heart failure linked with users consuming Onglyza and also Kombiglyze XR.
Does Onglyza Increase The Chance of Developing Pancreatic Cancer?
Onglyza forces the pancreas to release a high amount of insulin. This is one of the reasons why most Onglyza users face a threat of suffering from pancreatitis and pancreatic cancer.
A 2013 study on the effect of DDP-4 inhibitors on the pancreas shows that participants with type-2 diabetes consuming Onglyza had a higher risk of an enlarged pancreas. And their health problems don’t end there. These patients also have high chances of precancerous cellular changes due to the effect of DDP-4 inhibitors in their pancreas. It is a clear indication that the patients may develop pancreatic cancer later.
This was not a standalone study. Even the FDA conducted another research that year to check the safety of Onglyza and whether it really led to precancerous cellular changes or pancreatitis. The result was alarming. It showed that DDP-4 inhibitors used incretin mimetic to treat type-2 diabetes. And it wasn’t just Onglyza doing the damage. Drugs like Januvia, Byetta, and Nesina were equally responsible for the grave danger of inviting cardiovascular diseases.
The FDA conducted another study in 2014 to confirmed that people taking Onglyza were more likely to have pancreatic cancer. However, the researchers didn’t find anything significant to link Onglyza with this disease.
Is Onglyza Linked To Thyroid Cancer?
Victoza is an incretin mimetic with traits similar to Onglyza. This drug not only caused acute pancreatitis in rodents but also malignant thyroid cancer. Similar to the case of Onglyza, the FDA warned Victoza manufacturers to state the risk of thyroid cancer after consuming this drug. In fact, the FDA had, by that time, received multiple reports of people consuming Victoza and were diagnosed with thyroid cancer. There were two more prescribed incretin mimetics on that list: Januvia (sitagliptin) and Byetta (exenatide).
Has There Been A Recall Of Onglyza?
The FDA has not announced a recall of Onglyza and it is highly unlikely that it will happen any time soon. Although there are risks of cancer, heart failure, and other fatal diseases associated with this disease, a recall isn’t forthcoming. Does that mean the FDA doesn’t recall any harmful drug? No. It did recall Vioxx, a medicine that led to strokes and heart attacks. But you shouldn’t write off the fate of Onglyza just yet. Experts believe that the FDA will recall this drug and other incretin mimetics that lead to heart failures.
The only thing you can expect now is a statutory warning label on the medicine. You may still have to consume the medicine, knowing its side-effects.
Are There Any Ongoing Class Action Lawsuits Involving Onglyza?
Usually, very few drug injury lawsuits come under “class action.” Plaintiffs usually don’t want to represent cases against drug companies. It’s the victim that needs to file the case alone.
The U.S Judicial Panel on Multidistrict Litigation consolidated all the existing lawsuits against Onglyza and Kombiglyze in January 2018. By May 2018, nearly 100 cases formed consolidated litigation called MDL 2809. Some of the lawsuits that couldn’t become a part of this litigation are pending at the California State Court.
Can A Lawsuit Against Onglyza Be Filed Even If It’s Not Recalled?
The FDA panel clearly suggested that Onglyza manufacturers should include the warning of heart failures on the labels of this medicine. Many manufacturers are questioning this new rule as there were no such instructions when the medicine was first introduced ten years ago.
This means that patients who consumed Onglyza over the last 10 years didn’t know about this health risk at all. They may have suffered severe side-effects without knowing their causes.
According to the new Los Angeles, CA, law, patients who used Onglyza in the last decade and suffered heart failure may seek compensation from the respective pharmaceutical companies as they had failed to provide any safety warnings about the possible side-effects of this drug.
Get Help With Your Los Angeles Onglyza Lawsuit From An Attorney
At Rueb Stoller Daniel, we have dedicated class action attorneys who can help you file a case against the pharmaceutical company regarding the side-effects of Onglyza. If you or your loved one was hospitalized or suffered heart failure after consuming this drug, don’t hesitate to contact us. We have experience in representing people with similar cases from various parts of the USA. Our attorneys know that pharmaceutical companies like AstraZeneca and Bristol Myers Squibb are responsible for letting patients and doctors know about the risks of Onglyza. If they fail to provide any warning, our lawyers will fight tooth and nail to help you win your compensation if anyone in your family suffers a heart failure after taking this medicine.
We are here to prove that these manufacturers didn’t warn the users of possible side-effects of Onglyza. Our Los Angeles class-action law firm has experience in dealing with Onglyza-related cases. We are aware of where the flaw in the system is. This helps us to win cases against Onglyza manufacturers. Get in touch with us at (833) 44-DRLAW for a free consultation today.